A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients-Reference-Cited by-同舟云学术

A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients

Published:2023-09 Issue: Volume:191 Page:112965
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Liang Yu-Jing,Chen Qiu-Yan,Xu Jing-Xiao,Liu Xiu-Feng,Xia Jian-Chuan,Liu Li-Ting,Guo Shan-Shan,Song Bin^ORCID,Wang Pan,Li Ji-Bin^ORCID,Liu Qing^ORCID,Mo Hao-Yuan,Guo Ling,Sun Rui,Luo Dong-Hua,He Jia,Liu Yi-Na,Nie Cai-Ping,Tang Lin-Quan,Li Jiang^ORCID,Mai Hai-Qiang

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): an update on 26 trials and 7080 patients;Blanchard;Clin Transl Radiat Oncol,2022

3. What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis;Ribassin-Majed;J Clin Oncol,2017

4. The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: a cohort study from 1990 to 2012;Sun;Int J Radiat Oncol Biol Phys,2019

5. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial;Chen;Lancet Oncol,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

2. Current status and perspectives of clinical trials for tumor-infiltrating lymphocyte therapy;Clinical and Translational Oncology;2024-07-30

3. New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication;MedComm;2024-05-23